CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

计划入组 6,103 人 · 首次发布于 2010 年 11 月 18 日

Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

计划入组 40 人 · 首次发布于 2012 年 3 月 7 日

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

计划入组 227 人 · 首次发布于 2008 年 8 月 22 日

Glimepiride(Duetact, Tandemact)

C₂₄H₃₄N₄O₅S · Rx

Linagliptin(Glyxambi, Jentadueto, Tradjenta, Trajenta, Trijardy)

C₂₅H₂₈N₈O₂ · Rx

Linagliptin/Fimasartan Potassium Trihydrate

COMBINATION THERAPEUTICS AUSTRALIA PTY LTD

Australia

AURA FAT PROJECTS ACQUISITION CORP

Channel Infrastructure NZ Ltd

CDSCO Expert Panel Mandates Protocol Revisions for Glimepiride-Linagliptin Combination Phase III Trial

Glenmark Expands Diabetes Care Portfolio with Launch of Empagliflozin and Fixed-Dose Combinations in India

Delhi High Court Upholds Ban on Triple-Drug Diabetes Combinations, Supreme Court to Review